BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1776140)

  • 1. The effect of the carboxy-terminal lysine of urokinase on the catalysis of plasminogen activation.
    Lenich C; Pannell R; Gurewich V
    Thromb Res; 1991 Oct; 64(1):69-80. PubMed ID: 1776140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural and functional characterization of mutants of recombinant single-chain urokinase-type plasminogen activator obtained by site-specific mutagenesis of Lys158, Ile159 and Ile160.
    Lijnen HR; Nelles L; Van Hoef B; Demarsin E; Collen D
    Eur J Biochem; 1988 Nov; 177(3):575-82. PubMed ID: 2973984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A transitional state of pro-urokinase that has a higher catalytic efficiency against glu-plasminogen than urokinase.
    Liu JN; Pannell R; Gurewich V
    J Biol Chem; 1992 Aug; 267(22):15289-92. PubMed ID: 1639775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The kinetics of plasminogen activation by thrombin-cleaved pro-urokinase and promotion of its activity by fibrin fragment E-2 and by tissue plasminogen activator.
    Liu JN; Gurewich V
    Blood; 1993 Feb; 81(4):980-7. PubMed ID: 8428004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of fibrinogen and its cleavage products on the kinetics of plasminogen activation by urokinase and subsequent plasmin activity.
    Lucas MA; Straight DL; Fretto LJ; McKee PA
    J Biol Chem; 1983 Oct; 258(20):12171-7. PubMed ID: 6226655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fragment E-2 from fibrin substantially enhances pro-urokinase-induced Glu-plasminogen activation. A kinetic study using the plasmin-resistant mutant pro-urokinase Ala-158-rpro-UK.
    Liu JN; Gurewich V
    Biochemistry; 1992 Jul; 31(27):6311-7. PubMed ID: 1385727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation pathway of glu-plasminogen to Lys-plasmin by urokinase.
    Takada A; Takada Y
    Thromb Res; 1982 Sep; 27(6):671-7. PubMed ID: 6129717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amino-terminal fragment of urokinase-type plasminogen activator inhibits its plasminogen activation.
    Sun Z; Zhang PX; Wang P; Gurewich V; Shen HY; Liu JN
    Thromb Res; 2002 Apr; 106(2):105-11. PubMed ID: 12182908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasminogen activation by single-chain urokinase in functional isolation. A kinetic study.
    Ellis V; Scully MF; Kakkar VV
    J Biol Chem; 1987 Nov; 262(31):14998-5003. PubMed ID: 3667621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complementary modes of action of tissue-type plasminogen activator and pro-urokinase by which their synergistic effect on clot lysis may be explained.
    Pannell R; Black J; Gurewich V
    J Clin Invest; 1988 Mar; 81(3):853-9. PubMed ID: 2963831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic analyses of the activation of Glu-plasminogen by urokinase in the presence of fibrin, fibrinogen or its degradation products.
    Watahiki Y; Takada Y; Takada A
    Thromb Res; 1987 Apr; 46(1):9-18. PubMed ID: 3590117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzymatic properties of single-chain and two-chain forms of a Lys158----Glu158 mutant of urokinase-type plasminogen activator.
    Lijnen HR; Van Hoef B; Nelles L; Holmes WE; Collen D
    Eur J Biochem; 1988 Feb; 172(1):185-8. PubMed ID: 2894309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The blockage of the high-affinity lysine binding sites of plasminogen by EACA significantly inhibits prourokinase-induced plasminogen activation.
    Sun Z; Chen YH; Wang P; Zhang J; Gurewich V; Zhang P; Liu JN
    Biochim Biophys Acta; 2002 Apr; 1596(2):182-92. PubMed ID: 12007600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of fibrin-bound plasminogen by pro-urokinase and its complementariness with that by tissue plasminogen activator.
    Gurewich V
    Enzyme; 1988; 40(2-3):97-108. PubMed ID: 2971533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of plasminogen by single-chain urokinase or by two-chain urokinase--a demonstration that single-chain urokinase has a low catalytic activity (pro-urokinase).
    Pannell R; Gurewich V
    Blood; 1987 Jan; 69(1):22-6. PubMed ID: 3790724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences between neonates and adults in the urokinase-plasminogen activator (u-PA) pathway of the fibrinolytic system.
    Ries M; Zenker M; Gaffney PJ
    Thromb Res; 2000 Nov; 100(4):341-51. PubMed ID: 11113278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of staphylokinase with different molecular forms of plasminogen.
    Lijnen HR; Van Hoef B; Collen D
    Eur J Biochem; 1993 Jan; 211(1-2):91-7. PubMed ID: 8425556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the esterase and human plasminogen activator activities of various activated forms of human plasminogen and their equimolar streptokinase complexes.
    Wohl RC; Arzadon L; Summaria L; Robbins KC
    J Biol Chem; 1977 Feb; 252(4):1141-7. PubMed ID: 851483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the high-affinity interaction between human plasminogen and pro-urokinase.
    Lijnen HR; Zamarron C; Collen D
    Eur J Biochem; 1985 Jul; 150(1):141-4. PubMed ID: 3926492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of molecular forms of plasminogen and plasmin-inhibitor complexes in urokinase-activated human plasma.
    Müllertz S; Thorsen S; Sottrup-Jensen L
    Biochem J; 1984 Oct; 223(1):169-77. PubMed ID: 6208893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.